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The regulation of gene expression in response to stress is an essential cellular protection mecha-
nism. Recent advances in tRNA modiﬁcation analysis and genome-based codon bias analytics have
facilitated studies that lead to a novel model for translational control, with translation elongation
dynamically regulated during stress responses. Stress-induced increases in speciﬁc anticodon wob-
ble bases are required for the optimal translation of stress response transcripts that are signiﬁcantly
biased in the use of degenerate codons keyed to these modiﬁed tRNA bases. These ﬁndings led us to
introduce the notion of tRNA modiﬁcation tunable transcripts (MoTTs – transcripts whose transla-
tion is regulated by tRNA modiﬁcations), which are identiﬁable using genome-wide codon counting
algorithms. In support of this general model of translational control of stress response, studies mak-
ing use of detailed measures of translation, tRNA methyltransferase mutants, and computational
and mass spectrometry approaches reveal that stress reprograms tRNA modiﬁcations to translation-
ally regulate MoTTs linked to arginine and leucine codons, which helps cells survive insults by dam-
aging agents. These studies highlight how tRNA methyltransferase activities and MoTTs are key
components of the cellular stress response.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
1.1. Cellular responses to stress and damage
1.1.1. Damage, stress and disease
The chemical nature of DNA, protein and lipids makes these
vital cellular macromolecules susceptible to damage from endoge-
nous and exogenous agents. Normal metabolic processes can pro-
duce alkylating agents (i.e., formaldehyde and nitrosamines) and
a wide array of reactive oxygen and reactive nitrogen species
(i.e., OH, H2O2 and NO) [1]. Similarly, environmental exposures
to pesticides, consumer products and radiation sources can also
promote cellular alkylation, oxidation and nitrosation damage.
Alkylating and oxidizing agents have the potential to disrupt the
cellular redox balance by depleting cellular glutathione levels
and can damage DNA, proteins and lipids [2–4]. DNA damage can
drive mutagenesis and the resulting DNA sequence changes
can drive carcinogenesis and cancer progression. Protein damagecan deplete the cell of vital activities, cause protein aggregation
and result in the formation of reactive carbonyls (i.e., advanced
glycation end products), with the latter two mechanisms
implicated in neurodegenerative diseases [5]. Lipid damage in
the form of peroxidation can generate DNA- and protein-damaging
agents, as well as disrupt cellular membranes. Lipid damage is
linked to both cancer and neurodegenerative disease [5]. Lastly,
disruption of cellular redox balance can promote inﬂammation,
with this being linked to a host of chronic diseases [6–8]. Cells
respond to all of these stresses by controlling expression of a
variety of response genes, including the DNA damage response.
1.1.2. DNA damage response
The DNA base and sugar moieties are subject to damage by oxi-
dation and alkylation that generate adducts and cause single- and
double-strand breaks [1]. All types of cells, ranging from simple
prokaryotes and eukaryotes to mammals, have built in defense
mechanisms to respond to chemical and physical changes to the
genome in the form of the DNA damage response. For example,
DNA double-strand breaks are recognized by sensor proteins,
which in turn recruit transducer proteins to activate a cascade of
signals. The activated DNA damage response will regulate the cell
cycle, increase the level of DNA repair proteins and in some cases
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DNA repair proteins can include MRN complex (Mre11-Rad51-
Nbs1), ATM, p53 and Brca1, to name a few, with disruptions
leading to genome instability syndromes and increased cancer
incidence [11–13]. Single-strand breaks, speciﬁc mismatches and
bulky DNA adducts will also activate the DNA damage response.
The signalling cascade linked to the DNA damage response will
optimize the cell for DNA repair and in most cases maintain the
integrity of the DNA and health of the cell and organism [14].
1.1.3. Heat shock and unfolded protein responses
In addition to DNA damage, alkylating and oxidizing agents can
promote protein damage to activate protein-stress response path-
ways [15–17]. Translation errors and compounds that disrupt post-
translational processing of proteins can also promote folding prob-
lems. The Streptomyces-produced nucleoside antibiotic mixture
Tunicamycin is a compound that prevents N-linked glycosylation
[18]. Misfolded and unfolded proteins are readily recognized by
cellular machinery and activate the cytoplasmic heat shock
response (HSR) and endoplasmic reticulum (ER)-associated
unfolded protein response (UPR) [19]. Both HSR and UPR activate
chaperone and signal transduction systems to refold proteins and
in some cases reprogram the cell. For example, the UPR will recog-
nize misfolded proteins in the ER lumen using a chaperone protein.
The activated UPR turns on an elegant signal transduction pathway
that includes splicing of a speciﬁc mRNA (i.e., HAC1 in budding
yeast) to promote the production of an active transcription factor
and up-regulation of systems to promote folding and, if prolonged,
promote cell death [20,21]. Tunicamycin components are classic
activators of the UPR [22]. An overactive UPR is implicated in the
pathogenesis of cancer and amyotrophic lateral sclerosis, Parkin-
son’s, Huntington’s and Alzheimer’s diseases [23].
1.1.4. Reactive oxygen species (ROS) and reactive nitrogen species
(RNS) response and detoxiﬁcation
ROS can include O2 and H2O2 from the mitochondria and OH
from Fenton reduction of H2O2 and breakdown of reactive nitrogen
species such as peroxynitrite (ONOO) [1]. ROS andRNS can damage
all types of biomolecules, including RNA, lipids, proteins and
carbohydrates, with damage and response best characterized for
DNA. Increased O2 and H2O2 levels inside the cell will promote the
oxidation of protein-based cysteine amino acids. The AP-1 like tran-
scription factors have harnessed oxidized cysteine to sense ﬂuxes in
cellular ROS levels and activate detoxiﬁcation systems [3,24]. Super-
oxide dismutase can detoxify O2 to produce H2O2, which is further
detoxiﬁed by catalase and glutathione peroxidase (Gpx) enzymes
to make H2O [3,25]. Gpx proteins require reduced glutathione as a
cofactor to detoxify H2O2 and have also been shown towork on per-
oxidized lipids [26,27], with many of the Gpx enzymes possessing
the amino acid selenocysteine (Sec) as a key catalytic residue.
Targeted changes in gene expression are the key to an appropri-
ate and efﬁcient response to DNA or protein damage or increased
ROS and RNS levels. Gene expression can be regulated at many dif-
ferent levels in eukaryotic systems, including transcription, trans-
lation and post-translational mechanisms. In this review, we will
focus on translational control mechanisms. Speciﬁcally we will
focus on how tRNA modiﬁcation enzymes regulate the translation
of key stress response proteins. In addition we will discuss how
tRNA modiﬁcation defects lead to protein errors, with the latter
phenotypes potentially exploitable for disease treatments.
1.2. tRNA modiﬁcations
1.2.1. tRNA structure and function
With their 30-linked amino acids, tRNA molecules are com-
posed of 70–90 nucleotides of linear sequence that folds into acloverleaf-shaped secondary structure and L-shaped tertiary
structure, which ﬁts into the tRNA binding sites (P and A) in
the ribosome. They are initially transcribed with canonical U, A,
C and G bases, but the nucleobases and ribose sugars are chemical
modiﬁed by a large system of enzymes to form one of >120 differ-
ent known chemical structures. There are 25–30 types of mod-
iﬁed ribonucleosides in an organism and an average of 11 and 13
modiﬁcations spread throughout each tRNA in yeast and humans,
respectively [28–32]. As shown in Fig. 1 for budding yeast, the
structures of these modiﬁcations on tRNA are highly diverse,
ranging in complexity from simple methylation to amino acid
conjugation to multi-step biosynthetic reactions leading to com-
plex ring structures [33,34]. To a certain extent there are con-
served locations for many of these modiﬁcations, such as the
presence of dihydrouridine (D) and pseudouridine (w) in the D
stem and loop and T stem and loop of many tRNAs, respectively.
There are also a large number of chemically distinct modiﬁcations
found in the anticodon stem and loop [35]. Interestingly, although
these non-canonical nucleosides can be located throughout the
structure of tRNA, the signiﬁcance of their functions remains elu-
sive. It was initially believed that these modiﬁed ribonucleosides
played mainly structural roles by stabilizing the unique secondary
and tertiary structures of tRNA. For example, the highly conserved
D imparts ﬂexibility [36], whereas w and 20-O-methylation
stabilize base stacking [33,34,37]. More importantly, the large
diversity of chemical structures in the anticodon loop, and espe-
cially at the wobble position, has been shown to be critical for
translational ﬁdelity, frame-shift prevention and translation
efﬁciency [33,34,38–40]. We recently expanded these roles for
wobble modiﬁcations to include ﬁne-tuning of the efﬁciency of
translation of codon-biased mRNAs from classes of stress
response genes [41–45]. The clear regulatory function of tRNA
modiﬁcations thus raises the issue of pathology and disease
caused by defects in tRNA function.1.2.2. Chemistry of modiﬁcation in anticodon stem and loop and its
link to translational control
The diversity of tRNA modiﬁcation structures, the fact that
some wobble base modiﬁcations are only found on a subset of
tRNAs that interact with select codons and the known role of wob-
ble modiﬁcations in modulating anticodon-codon interactions, all
suggest a role for anticodon stem and loop tRNA modiﬁcations in
regulating translation by virtue of their ability to control the rate
of translational elongation [33,34]. Indeed, if they play a regulatory
role, tRNA modiﬁcations must change in response to speciﬁc alter-
ations in cell state. In addition the changes must alter the codon-
reading properties of the associated tRNA. The variety of chemical
structures at wobble positions supports this model. In budding
yeast, 9 of the 24 modiﬁed ribonucleosides (Fig. 1) are found at
the wobble position 34 in tRNA [46]: w, hypoxanthine (I),
20-O-methylguanosine (Gm), 20-O-methylcytidine (Cm), 5-meth-
oxycarbonylmethyluridine (mcm5U), 5-methoxycarbonylmethyl-
2-thiouridine (mcm5s2U), 5-carbamoylmethyluridine (ncm5U)
and 5-carbamoylmethyl-20-O-methyluridine (ncm5Um). It is
important to note that the majority of these wobble modiﬁcations
occur at U, which gives this pyrimidine signiﬁcant regulatory ﬂex-
ibility in reading a codon. For example, yeast tRNA methyltransfer-
ase 9 (Trm9) participates in the biosynthesis of mcm5s2U and
mcm5U by adding the ﬁnal methyl group at wobble positions in
ﬁve tRNA species (tRNAArg(UCU), tRNAGly(UCC), tRNALys(UUU),
tRNAGln(UUG) and tRNAGlu(UUC)) [47,48]. It has been shown that
tRNAArg(UCU) plays a central role in the response to alkylating
agents, with enhanced translation of mRNAs containing its cognate
AGA codon [45]. Another feature of wobble modiﬁcations is their
frequent tRNA speciﬁcity. For example, tRNA methyltransferase 4
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Fig. 1. Stress-induced changes in tRNA modiﬁcation as measured by LC–MS/MS. Budding yeast contain 25 modiﬁed ribonucleosides, of which 23 can be measured by
chromatography-coupled tandem mass spectrometry (LC–MS/MS). Following tRNA isolation and hydrolysis, individual modiﬁed ribonucleosides are resolved by reversed-
phase HPLC and quantiﬁed by tandem mass spectrometry. The data are used to calculate fold-change values comparing control cells to stressed cells, with the fold-change
values analyzed by multivariate statistics to identify patterns of stress-induced changes. The heat map represents fold-change data for four mechanistically distinct toxicants
and shows both agent- and dose-speciﬁc signatures. The heat map image was reproduced from Chan et al. [41].
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most frequently at position 48 between the variable arm and T
stem loop [32]. However, tRNALeu(CAA) is the only tRNA with m5C
at the wobble position [32] and we have shown that this unique-
ness plays a role in the regulation of translation during the oxida-
tive stress response [42]. The role of wobble base methylation of
pyrimidine nucleobase structures thus emerges as a central feature
of a tRNA-based translation regulatory system.1.3. tRNA methyltransferases
1.3.1. General reaction mechanism
tRNA methyltransferases (Trm) transfer the methyl group from
S-adenosyl methionine (SAM) to the 20-OH of the ribose sugar, to
the carbon and nitrogen atoms of the nucleobase, or to nucleophilic
sites in modiﬁcation intermediates (some examples are shown in
Fig. 2). There are 18 known Trm enzymes in Saccharomyces cerevi-
Fig. 2. tRNA modiﬁcations and their relation to stress signaling pathways.
Description of mutant phenotypes for cells deﬁcient in Trm9 and Trm4, structure
of substrates and products for each enzyme catalyzed tRNA modiﬁcation, the
pathways regulated by each tRNA methyltransferases, and pathways whose
activation is prevented (underlined) by proper tRNA modiﬁcation, via the preven-
tion of amino acid misincorporation errors.
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many cases, and for both Trm4 and Trm9, there are 2 or more
human homologs for each yeast Trm, which suggests diversiﬁca-
tion or specialization of Trm activity to new modiﬁcations in
humans, modiﬁcation of different tRNAs or RNA substrates, or
functions other than tRNA modiﬁcation. Such is the case for the
human Trm9 homologs, ALKBH8 and hTRM9L. There is also a
diversity of function among Trms, with ALKBH8 homologs in mam-
malian, bacterial and protozoan cells showing DNA dealkylation
repair activity and RNA oxidation activity, both derived from the
Fe(II) and 2-oxoglutarate-dependent oxygenase domain of the
protein [50]. Mammalian and plant ALKBH8 homologs are
tRNA hydroxylases that convert mcm5U to (S)-5-meth-
oxycarbonylhydroxymethyluridine (mchm5U) at the wobble posi-
tion of tRNAGly(UCC) [51,52]. At the same time, ALKBH8 also
catalyzes methylation of wobble U derivatives to form mcm5U
and mcm5s2U in certain tRNA species, such as the tRNA for Sec
[51,53–55]. Regardless of enzyme identity or regulation, modiﬁed
ribonucleosides can promote tRNA structural stability and folding,
translational ﬁdelity, frame-shift prevention and translation efﬁ-
ciency, with evidence for roles in tRNA quality control, cellular
stress responses and cell growth [34,38–40,46,56,57].
1.3.2. Human tRNA modiﬁcation systems and disease
Akin to the emerging recognition of defects in tRNA aminoacyl
synthases in a variety of human diseases [58], several clinical
observations point to critical roles for tRNA modiﬁcations in
human diseases such as cancer. This point is illustrated with
ALKBH8 and hTRM9L human homologs of yeast Trm9 [51,53,54].
ALKBH8 has been shown to be over-expressed in human bladder
cancers and thought to be anti-apoptotic, as silencing its expres-
sion down-regulated NOX-1 activity and caused activation of the
JNK and p38 pathway, leading to increased apoptosis [53]. Its
homologous partner, hTRM9L, on the other hand, appears to be
epigenetically silenced in breast, testicular, bladder and colon can-
cers [59]. Indeed, re-expression of hTRM9L in SW620 and HCT116
colorectal cancer cell lines, in which hTRM9L is silenced, sup-
presses tumor growth and promotes senescence [59]. We also notethat hTRM9L maps to the short arm of chromosome 8, a region
commonly lost or silenced in many cancers, including colorectal
and breast [60–64]. Available data suggest a model in which
ALKBH8 and hTRM9L have opposing roles in managing cell survival
and cell death. For example, ALKBH8 has been shown to be vital for
cell viability in late stage tumors, with knockdown leading to cell
death [53]. Similarly, turning off hTRM9L in late stage tumors is
required for them to grow, [59,64,65] as re-expression of TRM9L
in late-stage models drives these cells into senescence [59].
1.3.3. Yeast tRNA modiﬁcation systems and associated phenotypes
Biochemical characterization of tRNA modiﬁcation systems in
Escherichia coli and S. cerevisiae has led to the identiﬁcation of
many of the proteins and synthetic steps needed to generate spe-
ciﬁc tRNA modiﬁcations. The creation and systematic use of a
library of S. cerevisiae gene deletion mutants have also allowed
researchers to observe the association between tRNA modiﬁcation
deﬁcient cells (i.e., trmD) and stress phenotypes (examples in
Fig. 2). Deletion of a speciﬁc tRNA modiﬁcation system can lead
to global or speciﬁc hypo-modiﬁcation of tRNA. Hypo-modiﬁcation
of tRNA is linked to disease pathology in humans, with speciﬁc
under-modiﬁcation of yeast tRNA leading to sensitivity to agents
that promote increased ROS, DNA damage and protein errors. For
example, trm4D cells are sensitive to killing by H2O2, suggesting
that they have a compromised response to ROS-inducing agents,
which could be due to decreased translation of a critical detoxiﬁca-
tion protein (Fig. 2) [42]. Sensitivity to agents that promote DNA
double-strand breaks and S-phase damage (IR, MMS and HU) have
been demonstrated for trm9D cells, which could be due to a defect
in the translation of critical DNA replication activity [44,66]. In
support of this translation defect idea, trm9D cells demonstrate
sensitivity to aminoglycoside antibiotics that promote protein syn-
thesis errors, with the cells revealing increases in arginine for ser-
ine misincorporation events and frame-shifting [66]. The
aminoglycoside-induced sensitivity and increased translational
errors in trm9D cells promote protein errors and misfolding, with
the absence of Trm9 leading to activation of the UPR and HSR
(Fig. 2). Notably tRNA modiﬁcation deﬁcient strains have reported
phenotypes that include slow growth and sensitivity to 5-ﬂuoro-
uracil, ultra-violet radiation, cycloheximide and heat, with each
phenotype potentially due to defects in stress signalling and/or
protein synthesis [67–70].
The connection between stress phenotypes, hypo-modiﬁcation
of tRNA, and protein synthesis defects in trm mutants supports
the idea that there may be a distinct translational response to
stress. To help decipher the translational responses, new technolo-
gies and analytic approaches have been developed. Coming in the
form of mass spectrometry-based ribonucleoside analysis and gen-
ome-wide codon bias analytics, these approaches have helped link
tRNAmodiﬁcations to the regulation of critical stress response pro-
teins. Systems-based approaches reveal that groups of codon-
biased transcripts over-use codons that can be linked to speciﬁc
tRNA modiﬁcations, with subsequently translated proteins also
functioning in stress response pathways. Together, these results
support the idea that many stress response proteins are translated
from tRNAmodiﬁcation tunable transcripts (MoTTs), a concept dis-
cussed in detail below.
1.4. Methyl-based modiﬁcations regulate gene expression
1.4.1. Transcriptional regulation by m5C
We have observed a critical role for tRNA modiﬁcations, and
tRNAmethylation in particular, in the control of translation follow-
ing stress. A common theme associated with the control of gene
expression, and in some cases epigenetics, is the use of enzyme-
catalyzed methylation to regulate transcription, with the
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in response to environmental stimuli or in different cancers. For
example, enzyme-catalyzed methylation by DNA methyltransfer-
ases (DNMT’s) to form m5C is a well-established regulator of gene
transcription [71–74], with methylation patterns in some pro-
moter regions reprogrammed by stress or altered in some cancers
[75,76]. Promoter CpG methylation can silence the transcription of
tumor suppressor activities leading to decreased DNA damage
signaling and DNA repair, thus contributing to the etiology of
different cancers [76]. Histone methylation by protein methyl-
transferases (PMT’s) functions in a similar manner as a well-
recognized regulator of gene expression, with the ‘‘epigenetic’’
methylation marks occurring on histone tails [77]. As part of an
integrated system with DNA methylation, histone methylation is
theorized to be part of a complicated ‘‘histone code’’ that is altered
by environmental signals and disease pathologies to control gene
expression. Lysine N7-methylation (H3K4, H3K36) in histone H3
and the subsequent demethylation are considered to be dueling
signals that regulate transcription. At their simplest, both promoter
and histone methylation affect gene expression by regulating how
much of a transcript is made, with these epigenetic signals altered
in cancer to drive pathogenesis and reprogrammed after environ-
mental exposures. However, the simplicity of methylation as the
sole chemistry of epigenetic marks has now been complicated by
the emergence of 5-hydroxylmethylcytidine, 5-formylcytidine
and 5-carboxycytidine as putative epigenetic marks in DNA [78].
1.4.2. tRNA methylation and translational regulation
In parallel with DNA and histone protein methylation, we intro-
duce the concept of RNA modiﬁcations, including RNA methyla-
tion, as marks that reprogram in response to environmental
changes and control gene expression at the level of translation.
We and others have demonstrated that tRNA modiﬁcation
enzymes and their homologs are tumor growth suppressors and
down-regulated in some cancers [59] [64,79]. We have also
observed that tRNA methylation affects gene expression by regu-
lating how well a transcript is translated [41–45,66]. The DNA
and RNA modiﬁcation activities represented by DNMTs, PMTs
and Trms share a common theme of regulating gene expression
by enzyme-catalyzed methylation, with altered regulation/pat-
terns linked to environmental exposure and cancer. The concept
of tRNA wobble methylation expands methylation signals to regu-
lators of translation and links tRNA modiﬁcations and Trms to the
synthesis of proteins vital to stress responses [41–45,66]. A major
problem with studying RNA modiﬁcation signals is the availability
of technology to analyze and quantify them, which we have solved
by developing a novel bioanalytical and bioinformatic platform.
1.5. Stress-induced changes in tRNA modiﬁcation levels are linked to
MoTTs
1.5.1. Quantifying changes in tRNA modiﬁcation levels: a mass
spectrometry and bioinformatic platform for identifying and
quantifying modiﬁed ribonucleosides
The model we have developed posits tRNA modiﬁcations as
regulatory elements, which requires that they be coordinately
regulated and dynamically altered in response to a stimulus.
Following on our initial observations linking tRNA wobble mcm5U
and selective translation of codon-biased mRNAs in response to
alkylation stress [45], we undertook an assessment of stress-
induced changes in the full set of 24 tRNAmodiﬁcations in budding
yeast, with the goal of identifying patterns and behaviors for
different stresses. To facilitate this systems-level analysis, we
developed a chromatography-coupled mass spectrometry
(LC-MS) platform [80] that entails (1) RNA isolation and HPLC puri-
ﬁcation of tRNA [81], (2) enzymatic hydrolysis to ribonucleosidesfor reversed-phase HPLC resolution, (3) mass spectrometry-based
identiﬁcation and quantiﬁcation of individual ribonucleosides
and (4) multivariate statistical analysis of the resulting fold-change
data comparing controls to treatment conditions (Fig. 1) [41,42,80].
We then used this platform to analyze changes in the levels of
tRNA modiﬁcations after exposing yeast to equitoxic doses of four
mechanistically distinct toxicants: H2O2, MMS, sodium arsenite
(NaAsO2) and sodium hypochlorite (NaOCl). As we reported [41],
the levels of 23 tRNA modiﬁcations uniquely changed in response
to each toxicant, with hierarchical clustering of fold-change data
distinguishing both agent and dose as signature patterns of
increase and decrease. These stress-speciﬁc patterns of tRNA mod-
iﬁcation changes were then linked to selective translation of
codon-biased mRNAs for stress response proteins [42], which
raises the concept of MoTTs.
1.5.2. MoTTs: codon speciﬁc regulation of translation
Changes in wobble base tRNA modiﬁcation levels have the
potential to work in concert with codon usage patterns in speciﬁc
transcripts to regulate translation of response proteins. These can
be designated as modiﬁcation tunable transcripts (MoTTs), with
Fig. 3 detailing the methodology used to identify MoTTs in any
organism [43]. The concept of MoTTs is similar to the idea in mam-
mals that the transcription of some but not all genes can be regu-
lated by promoter methylation (m5C) and is analogous to
transcripts speciﬁc to enzymes containing Sec, a non-standard
amino acid with a tRNA that reads internal stop codons, as dis-
cussed in the next section. The idea is that the MoTTs preferentially
use one of several degenerate codons for an amino acid. In order to
identify MoTTs and evaluate the use of speciﬁc codons and codon
combinations in genes and gene networks, we developed a gene-
speciﬁc codon counting (GSCC) algorithm as a codon usage and sta-
tistical analysis tool. Further we employed the GSCC algorithm to
analyze the 5780 genes in S. cerevisiae [82]. Visualization
approaches were then used to identify distinct codon usage pat-
terns in speciﬁc genes and groups of genes. A computational anal-
ysis of S. cerevisiae cDNAs revealed 425 open reading frames that
possess statistically signiﬁcant deviations in the usage of 29
codons compared to other transcripts [45,82]. This over-usage
includes the presence of many non-preferred (i.e., non-optimal)
codons, relative to genome averages. The 425 codon-biased tran-
scripts represent potential MoTTs and they over- or under-use spe-
ciﬁc mono-codons throughout their open reading frames.
Interestingly, several quad-codon patterns (i.e., 4 repeats of a
codon) are well represented in the 425 identiﬁed transcripts. Many
of the MoTTs-associated codons are found in mixed codon boxes in
which wobble base tRNA modiﬁcations enhance interactions with
one codon (i.e., AGA for Arg) while restricting interactions with
others (i.e., AGC for Ser). Functional analysis of the 425 potential
MoTTs found that their corresponding proteins are over-repre-
sented in activities associated with protein synthesis, metabolism
and stress responses, with four prominent members of the DNA
damage response (RNR1-4) identiﬁed. As described in detail
shortly, several published studies support the idea that translation
of speciﬁc codon-biased transcripts can be regulated by tRNAmod-
iﬁcations, with stress response genes well represented in our list of
candidate MoTTs. This concept of codon usage, tRNA modiﬁcation
reprogramming and selective translation is illustrated by stop-
codon recoding for mRNAs of Sec-containing proteins.
1.5.3. Alkylation damage and mcm5U
One example of the connection between the modiﬁcation status
at a tRNA wobble position and cellular stress response is show-
cased in our report that the presence of mcm5U at the wobble posi-
tion of certain tRNA was crucial for cell survival following DNA
alkylation damage [45]. In S. cerevisiae, TRM9 catalyzes the
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Fig. 3. Genome-based identiﬁcation of MoTTs. Iterative analysis of each open reading frame is used to count the number of codons in each gene and determine the frequency
of use of synonymous codons for each amino acid (Steps 1 – 3). After analysis of all genes in a genome, the average value for all genes is then used to identify speciﬁc genes
that are over- (yellow) or under- (purple) using a codon, with groups of genes that have similar codon over- and under-usage patterns identiﬁed by clustering and heat map
visualization (Step 4).
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and mcm5s2U, which are found at the uridine wobble base of
tRNAARG(UCU) and tRNAGLU(UUC). The mRNAs for yeast translation
elongation factor 3 (YEF3) and ribonucleotide reductases 1
(RNR1) and 3 (RNR3) are over-represented with AGA and GAA
codons. YEF3, RNR1 and RNR3 ﬁt the criteria for MoTTs because
they over-use speciﬁc degenerate codons and the last two corre-
spond to established stress response activities. The basal transla-
tion of YEF3, RNR1 and RNR3 mRNA was found to be dramatically
decreased in trm9D cells lacking mcm5U and mcm5s2U in the
corresponding tRNA anticodons [45]. The decrease in the tRNA
modiﬁcations led to reduced expression of these key damage
response proteins even though the transcription of these genes
remained unperturbed, and ultimately caused enhanced suscepti-
bility of trm9D cells to DNA alkylation agents [45].
1.5.4. Oxidative damage and m5C
Previously, we showed that the S. cerevisiae Trm4-catalyzed
modiﬁcation of C to m5C at the wobble position of tRNALeu(CAA)
increased in response H2O2 exposure, which stimulated translation
of mRNAs (MoTTs) derived from the 38 genes in yeast in which 90%
or more of the leucines are encoded by UUG [42]. Among these
UUG-enriched MoTTs is that for the ribosomal protein Rpl22a,
one of two alternative proteins for Rpl22, which, in terms of mRNA
sequence, stands in sharp contrast with the mRNA for its paralog
Rpl22b that lacks signiﬁcant enrichment of UUG, despite apparent
homology at the amino acid level. As expected, H2O2 exposure did
not increase the rate of translation of Rpl22b, a non-MoTT, and
only deletion of the gene for Rpl22a, a MoTT, rendered the cells
sensitive to killing by H2O2-induced oxidative stress [42]. These
results provide a direct link between stress-induced increases in
a speciﬁc wobble tRNA modiﬁcation and enhanced translation of
codon-biased mRNAs for critical stress response genes. This again
illustrates the concept of MoTTs. Notably, mRNA levels for RPL22A,
YEF3, RNR1 and RNR3 are identical in wild-type, trm4D (for RPL22A)
and trm9D (for YEF3, RNR1, and RNR3) cells [42,45], which further
demonstrates that the tRNA modiﬁcation-dependent gene regula-
tion program operates at the level of translation.
1.5.5. Stop-codon recoding as a well-studied example of MoTTs
The connection between tRNA modiﬁcations and stress
response enzymes has previously been described during the
process of translational recoding. Sec is considered the 21st amino
acid and a dedicated codon for this amino acid is not found in the
genetic code. To accommodate incorporation of this non-standardamino acid, some organisms, including mice and humans, use an
internal stop codon (UGA) and speciﬁc sequences in the 30 untrans-
lated region (UTR) of the mRNA to signal for Sec incorporation. Sec
is the key active site amino acid in some Gpxs and thioredoxin
reductases (TrxRs). Many selenoproteins are regulated by selenium
levels and have stress response roles speciﬁc to the detoxiﬁcation
of ROS [83,84]. Sec is charged on speciﬁc tRNAs that contain anti-
codons that pair with the UGA stop codon, tRNASec(UCA), and the
enzyme-catalyzed tRNA modiﬁcations mcm5U and mcm5Um are
found at the wobble position. The modiﬁcations 1-methyladeno-
sine (m1A) at position 58,W at position 55, and isopentenyladeno-
sine (i6A) at position 37 are also found on tRNASec(UCA) [85]. The
presence of m1A, W, i6A and mcm5U is required for the formation
of mcm5Um, with the levels of this modiﬁcation being sensitive
to selenium concentration inside the cell and promoting a distinct
tertiary structure [86]. The two different states for tRNASec(UGA)
suggest a highly regulated modiﬁcation pattern and support the
translation of distinct subclasses of selenoproteins. Elegant studies
in mice have demonstrated that mcm5U and mcm5Um are required
for efﬁcient incorporation of Sec into speciﬁc selenoproteins
[54,87]. There are 25 selenoproteins in humans, as identiﬁed by
computational approaches that identify internal stop codons and
regulatory sequences [88]. From the perspective of codon usage,
transcripts corresponding to selenoproteins are severely biased
as they contain more than one stop codon, which is signiﬁcant
compared to the thousands of transcripts in humans that use stan-
dard amino acids and contain only a single stop codon. The concept
of codon bias being used to regulate the translation of stress
response proteins is an exciting prospect, and we put forth the
Sec transcripts are MoTTs.
1.6. Regulation of translation elongation
1.6.1. Model for increased translation by anticodon loop modiﬁcations
Studies on mcm5U and m5C support a general model (Fig. 4) in
which translation elongation is regulated to promote cellular stress
responses. The ability to change the kinetic and thermodynamic
properties of speciﬁc anticodon–codon interactions is linked to
wobble base tRNA modiﬁcations, making them ideal regulatory
points. Stress-induced increases in mcm5U andm5C (or any wobble
modiﬁcation) allow for increased decoding of speciﬁc codons,
which can be regulatory in MoTTs that over-use the codon. The
increased modiﬁcation of tRNA selectively increases the transla-
tion of MoTTs, which can, in effect, accelerate the translation of
speciﬁc transcripts and lead to increased levels of critical response
Oxidative  
stress 
reprograms 
tRNA 
Just-in-time: 
Stress  
response  
& survival  
proteins 
Selective translation  
of MoTTs:  
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modified 
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Fig. 4. Changes in tRNA modiﬁcation regulate the translation of MoTTs. The scheme
depicts the concept of stress-induced tRNA reprogramming and selective transla-
tion of codon-biased mRNAs (MoTTs) for oxidative stress in budding yeast.
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increase translational ﬁdelity, which should correspond to more
active proteins. Such decreased protein errors would allow the cell
to repurpose protein stress response systems during times of
increased external stimuli. Our model is supported by (1) codon
reporter systems and studies that support idea that speciﬁc codons
need speciﬁc tRNA modiﬁcations to be efﬁciently translated; (2)
the observation of increased wobble base modiﬁcations under spe-
ciﬁc stressors; (3) polysome proﬁles that demonstrate altered dis-
tribution of codon-biased transcripts in trm mutants; (4) matched
mRNA and protein studies that show decreased levels of critical
stress response proteins in trm mutants and (5) the observation
that speciﬁc tRNA modiﬁcations promote translational ﬁdelity
[41–45,66,84,89,90].
1.6.2. Potential for tRNA modiﬁcations to restrict translation
The other side of translational regulation is the potential to
down-regulate translation of speciﬁc proteins in response to envi-
ronmental changes. This idea is illustrated in our codon reporter
assays in budding yeast, which demonstrate that GAG-GAG-GAG-
GAG is translated at higher levels in trm9D cells relative to wild-
type cells [44]. This suggests that mcm5s2U tRNA modiﬁcations,
which are found in tRNAGlu that decodes GAG, can repress transla-
tion of mRNAs that contain speciﬁc codon sequences. We have
used our Gene-Speciﬁc Codon Counting database to identify 8
genes containing at P1 GAG-GAG-GAG-GAG sequence [82]. Func-
tional analysis of these proteins indicates that many are involved
in ribosomal RNA regulation and vesicle function.
1.7. Exploiting tRNA modiﬁcations for disease treatment
1.7.1. Cancer therapeutics
Carcinogenesis and cancer progression can be attributed to
many different endogenous and environmental agents that pro-
mote damage, cell stress or alter physiological conditions that pro-
mote cell growth. As described above, tRNA modiﬁcation systemsspeciﬁc to the anticodon loop of key tRNAs regulate cellular stress
responses and can promote the detoxiﬁcation of damaging agents
and efﬁcient DNA repair to prevent cell death. Regulating
responses to stress is a classic role for tumor suppressor proteins,
with p53 as the archetype. Defects in p53 can corrupt cellular
responses to DNA damaging agents, by preventing activation of
downstream components and cell cycle checkpoints. p53-inacti-
vating mutations are reported for many cancers and can allow
for increased proliferation of cancer cells [91–93]. Decreased
expression of known and potential tRNA modiﬁcation enzymes
have also been reported in lung and colorectal cancers. The
tRNA-isopentenyltransferase (tRNA-IPT) TRIT1 is responsible for
the formation of i6A and the modiﬁcation is found at position 37
of many tRNAs, most notably tRNASec. TRIT1 levels are decreased
in lung adenocarcinomas [79], which could compromise stress
responses and give TRIT1 a growth suppressive role in some lung
cancers. The human hTRM9L homolog of yeast Trm9 has been
identiﬁed as a tumor growth suppressor in colorectal cancers, with
deﬁciencies in hTRM9L found in speciﬁc cell models (SW620,
HCT116, LoVo) and colorectal tumors from the clinic. The tumor
growth suppressor role of hTRM9L suggests that it could be
involved in stress response regulation, with this under investiga-
tion. Based on data generated in bacterial, yeast and mammalian
cell culture models, deﬁciencies in speciﬁc tRNA modiﬁcation
enzymes and tRNA modiﬁcations should sensitize cancer cells to
particular therapeutics. For example, the tRNA-IPT activity is
required for modiﬁcation of tRNASec. Knockdown of tRNA-IPT or
failure to modify A37 leads to decreased selenoprotein levels
[94], with ROS detoxifying enzymes as notable members. These
data suggest that TRIT1-deﬁcient lung tumors would be sensitized
to therapeutics that promote increased ROS. Similarly, a deﬁciency
in hTRM9L has been shown to sensitize colorectal cancer cells to
killing by aminoglycoside antibiotics [59]. The US Food and Drug
Administration has already approved aminoglycoside antibiotics
for Gram-negative, select Gram-positive and protozoal infections.
Together with the cell-based killing data, this existing clinical use
makes aminoglycoside drugs like paromomycin and gentamicin
attractive personalized medical therapeutics for colorectal cancer.
1.7.2. Antibiotics
tRNA modiﬁcation enzymes may also serve as potential targets
for anti-fungal and antibiotic development, as they are already
used by competing organisms to kill other species. For example,
the mcm5s2U modiﬁcation of S. cerevisiae is targeted by killer toxin
system of Kluyveromyces lactis, with the associated endoribonuc-
lease cleaving the ASL of speciﬁc tRNAs to shut down translation
in S. cerevisiae [95,96]. A potential drug-able example is found for
TrmD, which is a tRNA methyltransferase that methylates a guan-
ine at position 37 of various bacterial tRNAs [97–100]. The gene for
TrmD is essential in many types of bacteria [98,99], which points to
its potential as an antibiotic target. In addition humans use a differ-
ent family of Mtase enzymes to methylate guanine at position 37,
which supports the idea that any drugs that target TrmD would be
speciﬁc to bacteria. Several groups have explored the development
of inhibitors of SAM binding to TrmD, with identiﬁcation of several
SAM analogs that bind with relatively high afﬁnity [101,102]. In
one case, fused thieno-pyrimidones were identiﬁed as competitive
inhibitors of SAM binding, with nanomolar binding afﬁnity and a
lack of activity against human homologs of TrmD [102].2. Conclusions and perspectives
In conclusion, we have described the technology and studies
that support the idea that dynamic tRNA modiﬁcations regulate
the translation of codon-biased transcripts. The unique reprogram-
4294 C. Gu et al. / FEBS Letters 588 (2014) 4287–4296ming of tRNA modiﬁcations observed after cells were treated with
DNA-damaging or ROS-inducing agents will most likely be a con-
served theme for responses to other distinct stressors. For example,
nutritional stress is predicted to promote reprogramming of tRNA
modiﬁcations to drive a translational response program, which
could also be coupled to tRNA degradation and altered aminoacy-
lation programs. We have made the case that tRNA modiﬁcation
reprogramming is tightly linked to MoTTs, with these distinct tran-
scripts serving as blue prints for translation. While we describe
MoTTs as having codon biases that signal for ‘‘on’’ or more transla-
tion, there exists a strong possibility that speciﬁc tRNA modiﬁca-
tion patterns can be used to signal for ‘‘off’’ and slow down
translation of speciﬁc transcripts. Turning off stress responses is
an important and understudied area, but from the perspective of
the cell, efﬁcient down-regulation of cellular programs (i.e., DNA
replication) can help protect against offending agents. There are
established and exploitable connections between tRNA modiﬁca-
tion systems and disease. We envision personalized cancer thera-
peutics that target speciﬁc modiﬁcation programs, with the tRNA
modiﬁcation signature giving cancers cells a growth advantage
but making them susceptible to a speciﬁc stressor. Aminoglycoside
antibiotics are potential route towards realizing this potential, but
further study and pharmacological optimizations are needed. Sim-
ilarly the targeting of organism speciﬁc tRNA modiﬁcation systems
also has great potential for treating infectious agents, as pathogen
speciﬁc Trms and their unique chemically modiﬁed tRNAs are
attractive targets.
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